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Abstract 
The selective inhibitor of the vacuolar proton-ATPase, concanamycin A, powerfully blocks influenza virus entry into cells, if present during the 
initial times of virus infection. Attachment of virus particles to cells is not prevented by concanamycin A, rather the exit of influenza virus from 
endosomes is the step blocked by this macrolide antibiotic. Inhibition of influenza virus entry into cells by concanamycin A or by nigericin takes 
place under acidic conditions. Moreover, if the pH gradient is abolished by pre-incubation of cells in acidic pH, influenza virus entry does not occur 
even in the absence of any inhibitors. These results indicate that acidic conditions per se are not sufficient o promote virus entry into cells; rather 
this step of virus infection requires a pH gradient. 
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1. Introduction 
Most animal viruses enter cells by receptor-mediated 
endocytosis. Viruses possessing a lipid membrane that 
surrounds the nucleocapsid contain glycoproteins in- 
volved in receptor recognition and virus entry into cells. 
After binding to cellular receptors virions are internal- 
ized and delivered to endosomes where the acid pH gen- 
erated by the vacuolar proton-ATPase induces the 
glycoproteins to undergo a conformational change [ 1,2]. 
These conformational changes in the virus fusogenic 
proteins that are located on the virion membrane xpose 
hydrophobic regions that permit their interaction with 
cellular membranes. This interaction triggers fusion be- 
tween the virion and cellular membranes [3-51. Experi- 
mental information favors this mechanism, particularly 
in the case of Semliki Forest virus and influenza virus 
[3-51. However, it is still uncertain to what extent recep- 
tor binding alone or in combination with low pH con- 
tributes to these conformational changes in virion com- 
ponents [6,7]. The use of compounds that raise the pH 
in endosomes has been crucial to define this model of 
animal virus entry. However, results obtained with these 
lysosome-active agents should be interpreted with cau- 
tion because some of them have side effects on several 
cellular and viral functions [8]. Therefore, the use of 
more selective and potent inhibitors is desirable to con- 
front the current models of virus entry into cells. 
The concanamycins are a family of macrolide antibiot- 
ics isolated from Streptomyces diastatochromogenes that 
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Abbreviations: hpi, hours post-infection; moi, multiplicity of infection; 
pfu, plaque-forming units. 
are highly active and selective inhibitors of the vacuolar 
proton-ATPase (v-[H+]ATPase) [9]. Here we show that 
the most selective and potent inhibitor of the V-[H’]ATP- 
ase, concanamycin A, blocks the entry of enveloped an- 
imal viruses into cells, even under acidic conditions in the 
medium. Our present results lend support to the concept 
that a pH gradient, in addition to low pH, is necessary 
to drive animal virus entry into cells. 
2. Materials and methods 
2.1. Viruses and cell culture 
Madin Darby canine kidney (MDCK) cells were grown on 100 mm 
plates in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 5% calf serum (G&co). Infection with influenza A virus (Victoria 
strain) was carried out in DMEM plus trypsin at 37°C in a CO, incu- 
bator. 
2.2. Antibiotics and ionophores 
Concanamycin A was obtained from Dr. K. Altendorf (University 
of Osnabriick, Germany). Nigericin was obtained from Sigma. 
2.3. Electrophoretic analysis of protein synthesis 
MDCK cells grown in 24-well plates were infected with influenza 
virus at a moi of IO-50 pfu/cell. After virus adsorption (time 0 of 
infection) the cells were washed and incubated in DMEM until 5.5 hpi. 
Then cells were labelled for 1 h with methionine-free medium contain- 
ing 20 &i [“Slmethionine per ml (1.45 Ci/mmol, Amersham). The 
radiolabelled cell monolayers were dissolved in sample buffer (62.5 mM 
Tris-HCI, pH 6.82% sodium dodecyl sulfate, 0.1 M dithiothreitol, 17% 
glycerol, and 0.024% Bromophenol blue as indicator). Samples were 
heated at 90°C for 5 min, applied to a 15% polyacrylamide gel and run 
overnight at 80 V. Fluorography was carried out in I M sodium salicyl- 
ate. The gels were finally dried and exposed to X-ray films. 
2.4. Electron microscopy 
MDCK cells grown on 35 mm diameter dishes were infected with 
influenza virus at a moi of 100 pfu/cell and incubated at 4°C for I h. 
The samples were fixed after I2 min incubation at 37°C with 2% (v/v) 
glutaraldehyde and 2% (w/v) tannic acid in phosphate-buffered saline 
(PBS) at room temperature for 30 min and washed three times with 
PBS. Post-fixation was carried out with 1% (w/v) 0~0, in PBS at 4°C 
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for 1 h. Samples were then dehydrated through a 30-100% (v/v) ethanol 
series and embedded in Epon 812 (Fluka Chemie AC?) after infiltration 
with ethanol:epon 812 (3: 1, I : 1 and 1: 3, v/v). En bloc staining was 
performed during the 70% ethanol step with 2% (w/v) uranyl acetate. 
Ultrathin sections were obtained with an Ultracut E Ultramicrotome 
(Reichert-Jung) using a diamond knife, stained with lead citrate, and 
washed with 20 mM NaOH and distilled water. Electron micrographs 
were taken with a JEOL 1010 microscope at 80 kV. 
2.5. Influenza virus entry at low pH 
MDCK cells were grown in L-24 linbro dishes in DMEM supple- 
mented with 5% fetal calf serum. Two different protocols were followed 
for influenza entry to the cells: (i) cells were cooled to 4°C and incu- 
bated with influenza virus (10 pfu/cell) on ice for 1 h. The inoculum was 
removed and replaced by DMEM without bicarbonate, buffered with 
20 mM MES, pH 5.2, or 20 mM HEPES, pH 7. Then, cells were 
incubated at 37°C in an atmosphere free of CO*. After 15 min the 
medium was replaced by DMEM and cells were incubated at 37°C until 
the labelling period. (ii) Cells were washed and concentrated influenza 
virus was added together with DMEM without bicarbonate buffered 
with 20 mM MES, pH 5.2, or HEPES, pH 7. Cells were incubated for 
a further 15 min in an atmosphere free of CO, and then washed and 
incubated in DMEM until the labelling period. 
3. Results and discussion 
To analyze the inhibitory effect of concanamycin A on 
virus infection, different concentrations of this com- 
pound were added during the initial stages of influenza 
virus infection. Concanamycin A was active at 5 nM and 
completely blocked influenza virus infection at 10 nM in 
MDCK cells (Fig. 1A). Treatment of uninfected cells 
with the same concentrations of the antibiotic showed no 
toxic effects, as measured by the capacity of these cells 
to synthesize proteins, even at 50 nM concanamycin A 
(Fig. 1A). The high specificity of concanamycin A in the 
inhibition of the v-[H’]ATPase [lo], and the fact that 
very low concentrations of this antibiotic inhibit virus 
entry, suggest hat this compound could be a useful tool 
for investigating the requirements for acidic conditions 
during different steps of infection of animal cells by vi- 
ruses. These findings suggest that concanamycin A 
blocks viral replication by inhibiting the v-[H’]ATPase, 
thus preventing acidification of endosomes and release 
of virions into the cytoplasm. To test whether the action 
of this agent was restricted to the early events of infec- 
tion, concanamycin A was added after virus entry (Fig. 
1A). Addition of the macrolide antibiotic 60 min after 
the virus did not inhibit infectivity, even if the compound 
was continuously present. These results suggest hat an 
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Fig. 1. Concanamycin A inhibits an early step of influenza virus infec- 
tion. (A) MDCK cells were mock-infected or infected with influenza 
virus at 50 pfulcell. Different concentrations of concanamycin A were 
added at the same time as the virus and cells were incubated for 1 h 
(0 min). Alternatively, concanamycin A was added after the cells were 
washed to remove the unadsorbed virus (60 min). Cells were incubated 
in DMEM until 5.5 hpi, then labelled for 1 h with methionine-free 
medium containing 20 PCi [‘?S]methionine per ml. (B) MDCK cells 
grown on 35 mm diameter dishes were infected with influenza virus at 
a moi of 100 pfu/cell and incubated at 4°C for 1 h in the presence (B-2) 
or absence (B-l) of concanamycin A (50 nM). The samples were fixed 
after 12 min incubation at 37°C. Electron micrographs were taken with 
a JEOL 1010 microscope at 80 kV as described in section 2. 
early event in virus infection is the target of concanamy- 
tin A. Certainly this event is not related to virus binding 
to receptors or internalization, since radioactive influ- 
enza virus binds to cells at 4°C and is internalized after 
binding with the same kinetics and to the same extent in 
the absence or in the presence of the antibiotic (data not 
shown). Finally, binding of influenza virus to the cell 
surface takes place both in the absence and presence of 
the inhibitor, as shown by electron microscopy (Fig. 1B). 
These findings suggest that the inhibition of the 
v-[H’]ATPase by concanamycin A prevents endosomal 
acidification, inhibiting virus release from endosomes. 
Fig. 2. Inhibition of influenza virus entry by concanamycin A and nigericin under acidic conditions. (A) Cells were pre-incubated with concanamycin 
A (50 nM) for 15 min at 37’C. Then two different protocols were followed. Preadsorption +: cells were cooled to 4°C and incubated with influenza 
virus (IO pfu/cell) on ice for 1 h. Then, the inoculum was removed and replaced by DMEM at pH 5.2 and the cells were incubated at 37°C for 15 
min in the presence or absence of the antibiotic. After that time the medium was replaced by neutral DMEM and cells were incubated at 37°C until 
the labelling period from 4.5 to 5.5 hpi. Preadsorption -: concentrated influenza virus was added to the cells in DMEM at pH 5.2. Cells were incubated 
for 15 min and then washed and incubated in neutral medium until the labelling period from 4.5 to 5.5 hpi. (B) Cells were treated with concanamycin 
A (50 nM) or nigericin (IOpM) or both for 15 min at 37°C. Then virus was added and allowed to absorb for I h at 4°C. After adsorption, the medium 
was replaced by DMEM buffered at pH 5.2 or 7. Cells were incubated for 15 min at 37°C in the presence or absence of the inhibitors and then washed 
and incubated in neutral DMEM before analysis of protein synthesis from 4.5 to 5 hpi. 
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Fig. 3. Inhibition of influenza virus entry by pre-incubation in acidic 
medium. Cells were washed and DMEM was replaced by DMEM 
without bicarbonate and buffered at pH 5.2. Influenza virus was added 
at the same time to the cells, and viral adsorption was allowed for I h 
at 4°C. Then, excess virus was removed and pre-warmed DMEM at the 
pH indicated was added for I5 min. Cells were washed again and 
incubated in DMEM for a labelling period from 4.5 to 5 hpi. 
Influenza virus particles can be induced to fuse directly 
with the plasma membrane by direct acidification of the 
culture medium [3,11]. Two different protocols were used 
to analyze the effect of concanamycin A on virus entry 
under low pH conditions: either the virus was added 
directly to cells in low pH medium, or the virus was 
pre-bound at 4°C under normal pH conditions and the 
cells were then incubated at 37°C in warmed low pH 
medium. Significantly, concanamycin A totally blocked 
infectivity of influenza virus added directly to low pH 
media (Fig. 2A). However, some virus infection is de- 
tected in the presence of the inhibitor if the virus is 
pre-bound to cells followed by uptake at pH 5.2. Effi- 
cient blockade of pre-bound viruses is achieved by com- 
bining concanamycin A and nigericin treatment (Fig. 
2B). Nigericin is an ionophore that facilitates exchange 
of H’ for K’ and thus dissipates any existing H’ gradient 
across the endosomal membrane. Therefore, our results 
indicate that virus entry can be prevented by inhibitors 
of endosomal functions, even under low pH conditions. 
We interpret these results to mean that viruses pre-bound 
to cells at 4°C and incubated in pre-warmed acidic me- 
dium are soon internalized into endosomes that have a 
pre-existing low pH, even if the v-[H’]ATPase is blocked. 
Hence, the viruses pre-bound to cell surface receptors 
can quickly leave the endosome before the pH gradient 
is dissipated due to the absence of a functioning v- 
[H’]ATPase and acidification of the cytoplasm. If the 
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viruses are added directly to low pH medium, however, 
virions must first bind to the cell surface; during this time 
protons from the external medium have acidified the 
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cytoplasm, with a consequent decrease in the pH gradi- 
ent across the endosomal membrane. Under these cir- 
cumstances, the activity of the v-[H’]ATPase is required 
to create a pH gradient sufficient to promote virus 
genome delivery to the cytoplasm. In addition, nigericin, 
an ionophore that exchanges K’ for H’, dissipates the 
proton gradient. Consequently, aclear inhibition of virus 
entry is achieved by adding nigericin that rapidly dissi- 
pates this proton gradient in the absence of an active 
v-[H’]ATPase, even in acidic media. 
Since the presence of the inhibitors used could influ- 
ence other unknown functions required for virus entry, 
we wanted to test whether entry of some animal viruses 
promoted by low pH required the existence of a pH 
gradient in the absence of any inhibitors. Cells were pre- 
incubated in acidic medium during virus binding. Under 
these conditions the intracellular pH rises, diminishing 
the pH gradient between the external medium (or en- 
dosomes) and the cytoplasm [12]. Under these circum- 
stances influenza virus was unable to infect cells when 
incubated at 37°C and low pH, whereas infection did 
occur if cells were placed in neutral medium, indicating 
that virus infectivity was not affected by preincubation 
in acidic medium (Fig. 3). These results lend support to 
the concept that the entry of some enveloped animal 
viruses requires a pH gradient in addition to low pH to 
promote virus infection. The biological implications are 
that viruses may need an energized membrane for proper 
fusion and virus entry into the cell. Indeed, the entry of 
both enveloped or naked animal viruses into cells dis- 
rupts the membrane potential [13-l 81. Therefore, animal 
viruses dissipate the ionic gradients during entry. The 
physiological significance of this behaviour may be to 
couple the proton motive force with virus entry into the 
cytoplasm [19]. 
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